These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 4545342)

  • 1. Prescriptions enter the political arena.
    Regier H
    J Leg Med (N Y); 1974; 2(2):24-30. PubMed ID: 4545342
    [No Abstract]   [Full Text] [Related]  

  • 2. Prescriptions enter the political arena.
    Regier H
    J Leg Med (N Y); 1974; 2(3):26-30. PubMed ID: 4546224
    [No Abstract]   [Full Text] [Related]  

  • 3. New York's generic drug substitution law.
    Kamen A
    N Y State Dent J; 1980 Nov; 46(9):599-604. PubMed ID: 6935574
    [No Abstract]   [Full Text] [Related]  

  • 4. Keeping prescription drugs safe and effective.
    Bryan PA
    Am Fam Physician; 1974 Nov; 10(5):189-93. PubMed ID: 4421343
    [No Abstract]   [Full Text] [Related]  

  • 5. Doctors are pivotal to prescription struggle.
    Chapman S
    Leg Aspects Med Pract; 1979 Mar; 7(3):42-4. PubMed ID: 423688
    [No Abstract]   [Full Text] [Related]  

  • 6. Benefits and liabilities of generic prescribing.
    Lee AM
    W V Med J; 1972 Jun; 68(6):161-6. PubMed ID: 4504384
    [No Abstract]   [Full Text] [Related]  

  • 7. FDA drug list: key to generic substitution.
    FDA Consum; 1979 Feb; 13(1):15-7. PubMed ID: 10308816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacy compounding of bioidentical hormone replacement therapy (BHRT): a proposed new approach to justify FDA regulation of these prescription drugs.
    Patsner B
    Food Drug Law J; 2008; 63(2):459-91. PubMed ID: 18561473
    [No Abstract]   [Full Text] [Related]  

  • 9. Additional generics on the market.
    FDA Drug Bull; 1986 Nov; 16(2):14-5. PubMed ID: 3817341
    [No Abstract]   [Full Text] [Related]  

  • 10. New York State and drug lists: a history of confusion.
    Stetler CJ
    Med Mark Media; 1978 Sep; 13(9):36, 38, 40 passim. PubMed ID: 10316687
    [No Abstract]   [Full Text] [Related]  

  • 11. The Massachusetts drug formulary.
    N Engl J Med; 1971 Jul; 285(4):232-3. PubMed ID: 5087728
    [No Abstract]   [Full Text] [Related]  

  • 12. "Genericgate".
    Marshall WJ
    Ohio Med; 1989 Nov; 85(11):831-2. PubMed ID: 2601929
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug substitution drive: bureaucratic tinkering.
    J Indiana State Med Assoc; 1979 Mar; 72(3):162. PubMed ID: 422860
    [No Abstract]   [Full Text] [Related]  

  • 14. Who really assures prescription drug quality?
    J Indiana State Med Assoc; 1979 Mar; 72(3):164. PubMed ID: 422862
    [No Abstract]   [Full Text] [Related]  

  • 15. Plugs for drugs.
    Masson A; Rubin PH
    Regulation; 1986; 10(1):37-43, 53. PubMed ID: 10280556
    [No Abstract]   [Full Text] [Related]  

  • 16. The debate continues on OTC switches.
    Giaquinta D
    Manag Care Interface; 2003 Jun; 16(6):49-50. PubMed ID: 12841076
    [No Abstract]   [Full Text] [Related]  

  • 17. Knowledge is power: legislative control of drug industry trade secrets.
    O'Reilly JT
    Spec Law Dig Health Care (Mon); 1987 May; 8(15):7-31. PubMed ID: 10281981
    [No Abstract]   [Full Text] [Related]  

  • 18. Another round over generics.
    Kosterlitz J
    Natl J (Wash); 1985 Oct; 17(42):2373, 2376. PubMed ID: 10274030
    [No Abstract]   [Full Text] [Related]  

  • 19. Prescription drug reimportation. Panacea or problem?
    Dalzell MD
    Manag Care; 2000 Dec; 9(12):22-7. PubMed ID: 11188358
    [No Abstract]   [Full Text] [Related]  

  • 20. Generic drug purchasing.
    Mehl B
    Hosp Pharm; 1988 Feb; 23(2):162-4 contd. PubMed ID: 10286432
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.